| QSAR studies of some thiazolo [4, 5-b] pyridines as novel antioxidant agents: enhancement of activity by some molecular structure parameters O Klenina, I Drapak, T Chaban, V Ogurtsov, I Chaban, I Golos Chemistry and Chemical Technology 7 (4), 397-404, 2013 | 31 | 2013 |
| Synthesis of Some Novel Thiazolo (4, 5-b) Pyridinesand their Tuberculostatic Activity Evaluation T Chaban, O Klenina, I Drapak, V Ogurtsov, I Chaban, V Novikov Chemistry & Chemical Technology, 287-292, 2014 | 29 | 2014 |
| Modern trends in diuretics development T Titko, L Perekhoda, I Drapak, Y Tsapko European Journal of Medicinal Chemistry 208, 112855, 2020 | 15 | 2020 |
| Synthesis of 2-(4-aryl (adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives and prediction of their biological activity HO Yeromina, IV Drapak, LO Perekhoda, VD Yaremenko, ... Der Pharma Chemica, 2016 | 15 | 2016 |
| Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl) thiazol-2-ylimino] thiazolidin-4-ones I Drapak, T Chaban, V Foliush, V Matiychuk Biointerface Research in Applied Chemistry 10 (3), 5507-5511, 2020 | 14 | 2020 |
| Cardiovascular calcium channel blockers: historical overview, development and new approaches in design I Drapak, L Perekhoda, T Tsapko, N Berezniakova, Y Tsapko Journal of Heterocyclic Chemistry 54 (4), 2117-2128, 2017 | 13 | 2017 |
| Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents CT Сhulovska Z, I Drapak, I Chaban, I Nektegaev Biointerface Res. Appl. Chem 11 (1), 8009-8017, 2021 | 12 | 2021 |
| HPLC method development for the analysis of bisoprolol in combined dosage form containing bisoprolol and enalapril and in vitro dissolution studied L Logoyda, S Kovalenko, AМ Abdel-Megied, I Zhulkevych, I Drapak, ... | 10 | 2019 |
| The antioxidant properties of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one derivatives under conditions of … LO Perekhoda, NP Kobzar, HO Yeromina, IV Drapak | 10 | 2017 |
| Approaches for synthesis and chemical modification of non-condensed heterocyclic systems based on 1, 3, 4-oxadiazole ring and their biological activity: A review M Lelyukh, M Martynets, M Kalytovska, I Drapak, S Harkov, T Chaban, ... Journal of Applied Pharmaceutical Science 10 (10), 151-165, 2020 | 9 | 2020 |
| Synthesis and in silico research of derivatives of 3-allyl-4-(R-phenyl)-N-(R1-phenyl) thiazole-2-imine LO Perekhoda, MM Suleiman, IA Sych, VD Yaremenko, IV Drapak | 9 | 2017 |
| A review on synthetic routes for obtaining of 2, 5-disubstituted 1, 3, 4-oxadiazoles via cyclodehydration and oxidative cyclization reactions M Lelyukh, I Chaban, L Shelepeten, I Demchuk, S Harkov, T Chaban, ... Biointerface Research in Applied Chemistry 10 (4), 5960-5971, 2020 | 8 | 2020 |
| Synthesis, anticancer and antioxidant properties of some 4-thioxo-thiazolidin-2-ones Z Chulovska, I Drapak, T Chaban, V Ogurtsov, I Chaban, V Matiychuk European Chemical Bulletin 10 (3), 147-154, 2021 | 7 | 2021 |
| Search for Biologically Active Substances with Antimicrobial and Antifungal Action in the series of 2.5-disubstituted 1, 3, 4-tiadiazoles IV Sych, IV Drapak, MM Suleiman, MV Rakhimova, NP Kobzar, IA Sych, ... Res J Pharm Tech 12 (6), 1-6, 2019 | 7 | 2019 |
| The use of the docking studies with the purpose of searching potential cardioprotectors I Drapak, L Perekhoda, O Vynogradova, M Protopopov, M Suleiman, ... Pharmacia 2, 40-46, 2018 | 7 | 2018 |
| Development of a Novel, Fast, Simple HPLC method for determination of atorvastatin and its impurities in tablets N Shulyak, M Piponski, S Kovalenko, T Bakovska Stoimenova, ... Scientia Pharmaceutica 89 (2), 16, 2021 | 6 | 2021 |
| Cardioprotective activity of some 2-arylimino-1, 3-thiazole derivatives I Drapak, L Perekhoda, N Demchenko, M Suleiman, M Rakhimova, ... Scientia Pharmaceutica 87 (1), 7, 2019 | 6 | 2019 |
| Докінгові дослідження та QSAR-аналіз 4-(3, 5-діарил-4, 5-дигідро-1-1Н-піразол-1-іл) пропіонової кислоти), які виявляють протиракову активність in vitro ДЯ Гаврилюк, БС Зіменковський, ІВ Драпак, ВВ Атаманюк, РБ Лесик Фарм журн 6, 69-75, 2009 | 6 | 2009 |
| QSAR-analysis of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4-yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one’s derivatives as potential antioxidants І Drapak, B Zimenkovsky, L Perekhoda, H Yeromina, K Lipakova, ... Pharmacia 66 (1), 33-40, 2019 | 5 | 2019 |
| Historical overview, development and new approaches in design of angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Part I I Drapak, O Kamenetska, L Perekhoda, I Sych Scripta Scientifica Pharmaceutica 3 (1), 19-33, 2016 | 5 | 2016 |
